Tue 19 Jul 2022
Video & Slides

Featuring presentation videos and accompanying slides: Sponsored by Bristol-Myers Squibb; Attendees were able to engage virtually with other Immuno-Oncology professionals from across the country and increase thier knowledge of myositis, uveitis, thyroiditis and gastrointestinal toxicities secondary to immunotherapy.

If you would like to attend a future event on this topic, please email our Customer Service Team or telephone 01732 897788. They will be happy to assist you.  

Practical Management of Immuno-Oncology (IO) Side Effects
On-demand 3 hours £299+VAT

3 hours Continuing Professional Development

An excellent opportunity to refresh your knowledge with a good balance between science and case studies. This dedicated forum focused on:

  • Developing protocols and improving management of GI side effects
  • Triaging and treating inclusion body myositis (IBM)
  • Assessing and managing uveitis secondary to immunotherapy
  • Recognising and treating thyroiditis secondary to IO
9:30
Introductions, instructions and chair’s opening remarks
Jacqui Warden, Oncology Advanced Nurse Practitioner, Oxford University Hospitals NHS Foundation Trust
Treating adverse effects
9:40
Developing protocols and improving management of GI side effects
  • Why do gastrointestinal toxicities present as side effects of immunotherapy?
  • Understanding the severity and when to escalate
  • Protocols to effectively manage toxicity: assessment, intervention, investigations and the MDT approach
Dr Vincent Cheung, Consultant Gastroenterologist, Oxford University Hospitals NHS Foundation Trust
Managing side effects
10:10
Assessing, triaging and treating immune-related musculoskeletal toxicities
  • Guidance for assessing symptoms: what to look out for and what to ask
  • Understanding when to escalate and when to initiate medication and rehabilitation
  • Case study examples: what lessons have been learnt?
Jacqui Warden, Oncology Advanced Nurse Practitioner, Oxford University Hospitals NHS Foundation Trust
10:40
Questions and answers with the speakers
10:50
Sponsored presentation from Bristol Myers Squibb
Jo Christon, Associate Director Field Access, Bristol Myers Squibb
10:55
Opportunity to meet Bristol Myers Squibb in the breakout rooms
In dedicated breakout rooms, you will have the opportunity to chat directly with Bristol Myers Squibb
11:05
Screen break
11:15
Interactive discussion: Benchmark your experience of assessing and managing toxicities
  • What is your experience of managing immunotherapy toxicity?
  • How many patients receiving immunotherapy do you review each week?
  • How do you educate other professionals about side effects and toxicities of immunotherapy?
  • What escalation processes do you have in place in your team?
11:35
Feedback from interactive discussion on Benchmark your experience of assessing and managing toxicities
Identifying toxicities
11:45
Assessing and managing inflammatory ocular complications secondary to immunotherapy
  • Guidance for managing and treating immunotherapy induced inflammatory eye disease
  • Assessing the symptoms and initiating early and effective treatment
  • Learning from case study examples: what to look out for, when to investigate and when to initiate treatment
Dr Tasanee Braithwaite, Consultant Ophthalmologist, The Medical Eye Unit, Guy's and St Thomas' NHS Foundation Trust and School of Immunology and Honorary Senior Lecturer, Microbial Sciences, King’s College London
12:15
Recognising and treating endocrine toxicity secondary to IO
  • Assessing the symptoms and initiating early testing and diagnosis
  • Achieving timely referral and treatment of immunotherapy related endocrine toxicity
  • Initial management of thyroid and pituitary IO toxicity
  • Learning from case study examples: what to look out for, when to investigate and when to initiate treatment
Dr Daniel Morganstein, Consultant Endocrinologist, Chelsea and Westminster Hospital NHS Foundation Trust
12:45
Questions and answers with the speakers
12:55
Chair’s closing remarks and close of online forum

Your confirmed speakers to date:


Job Title:
Oncology Advanced Nurse Practitioner
Organisation
Oxford University Hospitals NHS Foundation Trust
Biography

Jacqui works as an Advanced Nurse Practitioner at the Churchill Hospital in Oxford, running nurse-led clinics in renal, prostate and lung cancers for patients receiving Systemic Anti-Cancer Treatments (SACT). As a non-medical prescriber, Jacqui provides patients with a comprehensive review and support service during active treatment both in clinic and in the Oncology Day Treatment Unit. Jacqui is Team Leader for the Oxford SACT Specialist Nurse Team.


Job Title:
Consultant Gastroenterologist
Organisation
Oxford University Hospitals NHS Foundation Trust
Biography

Dr Vincent Cheung is a Consultant Gastroenterologist at Oxford University Hospitals NHS Foundation Trust. He co-runs a tertiary GI liaison service for immune-related adverse events managing patients from the Oxford Cancer Centre and other regional centres. Having graduated from University of Cambridge, he trained in London and Oxford, and completed a fellowship at the Royal Free GI Neuroendocrine Tumour unit. His clinical interests are in GI irAEs, IBD and advanced endoscopy. He is accredited as a Bowel Cancer Screening colonoscopist. He completed research in immunotherapy-related GI and liver adverse events at Oxford and published this work in Gastroenterology, Gut, British Journal of Cancer and Frontline Gastroenterology.


Job Title:
Consultant Ophthalmologist and Honorary Senior Lecturer
Organisation
The Medical Eye Unit, Guy's and St Thomas' NHS Foundation and School of Immunology, Microbial Sciences, Trust King’s College London
Biography

Job Title:
Consultant Endocrinologist
Organisation
Chelsea and Westminster Hospital NHS Foundation Trust
Biography

Dr Daniel Morganstein is a Consultant Endocrinologist based at Chelsea & Westminster Hospital NHS Trust and Royal Marsden NHS Trust. 

He is an Honorary Clinical Senior Lecturer at Imperial College He has particular interests in endocrine tumours, including neuroendocrine tumours, adrenal tumours and paragangliomas, thyroid cancer, including medullary thyroid cancer, as well as in the endocrine toxicities of cancer therapy especially immunotherapy. 

He has further interests in the management of diabetes during cancer. 

He has recent publications in these fields.

Past attendee feedback

Following 3 hugely successful online forums, this event provided useful updates and friendly, helpful interactive discussions – but don’t take our word for it! Take a look at how past attendees have described our immunotherapy online forums over the past 2 years:

‘Enjoyable, clear speakers, opportunity to ask questions, well organised easy to navigate’

Ashford and St Peters Hospital, Practical Management of Immuno-Oncology (IO) Side Effects, July 2022

‘A good mix of learning options and styles. Good interactive groups to share experience, a good way to benchmark own experience and services’

United Lincolnshire Hospitals NHS Trust, Practical Management of Immuno-Oncology (IO) Side Effects, July 2022

‘Well organised and wide range of interesting topics.’

Royal Surrey NHS Foundation Trust, Practical Management of Immuno-Oncology (IO) Side Effects, July 2022

‘Very interesting to hear about management of more uncommon side effects such as eye disease, muscoloskeltal problems’

Worcester Royal Hospital, Practical Management of Immuno-Oncology (IO) Side Effects, July 2022

“An excellent morning. Really enjoyed the balance between the (complex) science of checkpoint inhibitors and case studies that illustrated the importance of careful assessment and multi-professional working relationships.”

Somerset NHS Foundation Trust, Recognising and Treating IO Side Effects, November 2021

“Excellent, relevant, worthwhile and informative. The best online forum I have attended.”

University Hospitals Trust Sussex NHS Foundation Trust, Recognising and Treating IO Side Effects, November 2021

“Great session with experts who were knowledgeable and explained things very well.”

Worcester Acute NHS Trust, Recognising and Treating IO Side Effects, November 2021

“Excellent. One of the best I've attended. Pitched perfectly and I understood it!”

West Hertfordshire Hospitals NHS Trust, Recognising and Treating IO Side Effects, July 2021

“I found it very friendly, and very informative. It was nice to talk to other areas before the presentations started in small groups and learn a bit about how other areas process are for triage and assessment of their patients.”

Sheffield Teaching Hospitals NHS Foundation Trust, Recognising and Treating IO Side Effects, July 2021

“I am so grateful for the knowledge acquired through my first virtual conference. It was very well organised with technical support provided, very efficient. Speakers were excellent and content very appropriate and relevant.”

Royal Surrey NHS Foundation Trust, Managing Side Effects of Cancer Immunotherapy, December 2020

“Informative, friendly and highly appropriate content. Really exciting day as it felt like networking and being present at a physical conference, so thank you for making it so warm and welcoming.”

Western Sussex Hospitals NHS Trust, Managing Side Effects of Cancer Immunotherapy, December 2020

View further comments on SBK Healthcare events on Trust Pilot.

Pricing structure

  • £299 + VAT for you to download and view in your own time
  • Click on 'Book Place' and complete your details

Terms and conditions

Purchase Fees 

You will receive an instant payment option or invoice on completing the booking form. Once your payment has been made, you will be given the access details to view the presentations on-demand. 

Certification of Attendance 

Please notify us when you have viewed the complete set of presentations. A certificate for Continuing Professional Development will then be sent to you so that you have a record of your continuing professional training and development. 

Privacy Notice 

To view the details on how your data is being collected and used, please view our Privacy policy.